These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
3. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
4. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395 [TBL] [Abstract][Full Text] [Related]
5. Generation of anti-tumor response by JAWS II mouse dendritic cells transduced with murine interleukin 12 genes. Pajtasz-Piasecka E; Rossowska J; Szyda A; Krawczenko A; Dus D Oncol Rep; 2007 May; 17(5):1249-57. PubMed ID: 17390073 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity. Yamaguchi S; Tatsumi T; Takehara T; Sasakawa A; Hikita H; Kohga K; Uemura A; Sakamori R; Ohkawa K; Hayashi N Cancer Immunol Immunother; 2008 Dec; 57(12):1861-9. PubMed ID: 18438665 [TBL] [Abstract][Full Text] [Related]
8. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
10. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity. Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590 [TBL] [Abstract][Full Text] [Related]
11. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W; He L; Cao X Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032 [TBL] [Abstract][Full Text] [Related]
12. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model. Jack AM; Aydin N; Montenegro G; Alam K; Wallack M J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model. Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857 [TBL] [Abstract][Full Text] [Related]
15. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal. Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303 [TBL] [Abstract][Full Text] [Related]
16. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines. Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927 [TBL] [Abstract][Full Text] [Related]
17. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination. Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201 [TBL] [Abstract][Full Text] [Related]
18. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma. Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233 [TBL] [Abstract][Full Text] [Related]
19. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG. Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012 [TBL] [Abstract][Full Text] [Related]
20. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model. Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]